{"filing":{"accession_number":"0001493152-26-033184","cik":"0001618835","ticker":"EVFM","company_name":"Evofem Biosciences, Inc.","form":"8-K","filing_date":"2026-07-14","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226033184/form8-k.htm"},"events":[{"id":17892,"run_id":16051,"accession_number":"0001493152-26-033184","anchor_item_number":"2.03","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Item 2.03 discloses creation of a direct financial obligation, with a Promissory Note dated July 8, 2026 attached as Exhibit 10.1. This is a classic debt issuance event. The filing references incorporation of Item 1.01 details (not shown here), which likely contains the material terms. For a biotech company like Evofem, debt issuance is material to investor assessment of capital structure and financial position.","company_name":"Evofem Biosciences, Inc.","ticker":"EVFM","filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16526,"accession_number":"0001493152-26-033184","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 discloses creation of a direct financial obligation, with a Promissory Note dated July 8, 2026 attached as Exhibit 10.1. This is a classic debt issuance event. The filing references incorporation of Item 1.01 details (not shown here), which likely contains the material terms. For a biotech company like Evofem, debt issuance is material to investor assessment of capital structure and financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:33:51.592107+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16526,"accession_number":"0001493152-26-033184","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 discloses creation of a direct financial obligation, with a Promissory Note dated July 8, 2026 attached as Exhibit 10.1. This is a classic debt issuance event. The filing references incorporation of Item 1.01 details (not shown here), which likely contains the material terms. For a biotech company like Evofem, debt issuance is material to investor assessment of capital structure and financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:33:51.592107+00:00","company_name":"Evofem Biosciences, Inc.","ticker":"EVFM","filing_date":"2026-07-14"}]}